Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1328-1335
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1328
Table 3 Association between PTTG1 expression and clinicopathological data of patients undergoing radical surgery for colorectal carcinoma
Grouping
n
PTTG1 positive (n = 58), n (%)
PTTG1 negative (n = 45), n (%)
χ2
P value
Sex2.7280.099
    Male5334 (58.62)19 (42.22)
    Female5024 (41.38)26 (57.78)
Age3.5340.060
    < 60 yr old4219 (32.76)23 (51.11)
    ≥ 60 yr old6139 (67.24)22 (48.89)
Tumor location2.3270.127
    Colon4328 (48.28)15 (33.33)
    Rectum6030 (51.72)30 (66.67)
Differentiation degree0.8670.352
    High differentiation2311 (18.97)12 (26.67)
    Low–moderate differentiation8047 (81.03)33 (73.33)
Pathological staging0.6160.433
    I–II4829 (50.00)19 (42.22)
    III–IV5529 (50.00)26 (57.78)
Lymph node metastasis17.150< 0.001
    Positive5843 (74.14)15 (33.33)
    Negative4515 (25.86)30 (66.67)